Together, these results indicate that the inhibitory effects of W54011 are primarily attributable to the blockade of C5a signaling, rather than to nonspecific cytotoxicity, and underscore its potential efficacy in targeting C5a-driven GBM stem-like phenotypes. This evidence concerns the gene C5AR1 and glioblastoma.